BTIG analyst Ryan Zimmerman maintained a Buy rating on Stryker Corporation (NYSE:SYK) on Thursday, setting a price target of $284, which is approximately 5.77% above the present share price of $268.5.
Zimmerman expects Stryker Corporation to post earnings per share (EPS) of $1.57 for the fourth quarter of 2021.
The current consensus among 5 TipRanks analysts is for a Strong Buy rating of shares in Stryker, with an average price target of $301.75.
The analysts price targets range from a high of $320 to a low of $284.
In its latest earnings report, released on 06/30/2021, the company reported a quarterly revenue of $4.29 billion and a net profit of $808 million. The company's market cap is $101.25 billion.
According to TipRanks.com, BTIG analyst Ryan Zimmerman is currently ranked with 5 stars on a 0-5 stars ranking scale, with an average return of 23.9% and a 56.41% success rate.
Michigan-based Stryker Corp. was founded in 1941. The company provides medical technology products and services. It operates its business through the following segments: Orthopaedics, MedSurg and Neurotechnology and Spine.